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As early as the 1940s, erythema multiforme exudativum (Stevens-Johnson syndrome) and
hemolytic anemia were associated with outbreaks ofatypical pneumonia, a disease later found
to be caused by Mycoplasma pneumoniae. Epidemiologic evidence has also associated
neurological complications, especially aseptic meningitis and meningoencephalitis, with M.
pneumoniae infections. Urticarial and morbilliform skin rashes often appear late in the course
of M. pneumoniae pneumonia. A multitude of other complications have been ascribed to M.
pneumoniae infections, often reported as case reports diagnosed by serologic antibody titers
only. More systematic investigations are needed to assess the frequency ofcomplications to M.
pneumoniae infections. Isolation ofthe agent, not only serologic titer rises, should be required
before a syndrome is attributed to M. pneumoniae infection.
The incidence of Mycoplasma pneumoniae pneumonia and minor infections has
been thoroughly studied in civilian and military populations (1-6]. The infection is
endemic in most areas ofthe world; epidemics occur at four- to seven-year intervals.
Infection rates in epidemics can be as high as 35 percent among school children, but
pneumonia is diagnosed in only a small proportion of those infected [2]. The large
epidemiological studies, observing civilian populations or military personnel by us-
ing isolation ofM. pneumoniae from respiratory specimens and serologic tests, have
rarely reported complications [2-6]. Instead, they described M. pneumoniae infec-
tions, including pneumonia, as mild. It is conceivable that patients who present with
extrapulmonary symptoms may escape detection in such studies. In contrast, physi-
cians who study patients hospitalized for pneumonia report more cases of severe
disease and complications [1,7]. Clearly, a selection for severity has already taken
place with hospitalization. In the Seattle field studies ofM. pneumoniae pneumonia
in a prepaid medical care group, only 2 percent of M. pneumoniae pneumonia pa-
tients were hospitalized [5].
Complications were reported as early as the 1940s, when atypical pneumonia was
first described and cold agglutinins were used for diagnosis. What is now usually la-
beled Stevens-Johnson syndrome was first associated with outbreaks of atypical
pneumonia among military recruits in Canada in the early 1940s [8]. Finland et al.
reported on four cases of erythema multiforme exudativum (Stevens-Johnson syn-
drome) during an epidemic of atypical pneumonia in Boston, 1942-1944 [9].
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All rights of reproduction in any form reserved.Hemolytic anemia was also reported during these epidemics [10]. However, the
cause of hemolysis could possibly be attributed to treatment with sulfonamides,
drugs commonly used as antimicrobial therapy at the time.
In 1956, Yesnick associated "aseptic pneumonia" with neurological complica-
tions, but at a very low rate [11]. In 1965, Skoldenberg noticed temporal association
between cold agglutinin positive pneumonia and aseptic meningitis in Stockholm
[12]. The latter patients usually also had positive chest findings.
Since more specific diagnostic tools for diagnosis of M. pneumoniae infection
became available in the 1960s, a large number of case reports of severe manifesta-
tions and complications have accumulated. These have been extensively reviewed
[13-15]. Too often the diagnosis was made in retrospect, from significant antibody
titer rise to M. pneumoniae between acute and convalescent serum. Few clinicians
have had the foresight to take cultures for M. pneumoniae in such cases; in fact,
many medical centers do not have access to a laboratory with competence and ex-
perience in mycoplasma isolation. Utilizing serologic diagnosis for a multitude of
disease syndromes introduces a risk of making false associations, since non-specific
increases in antibody titers to M. pneumoniae may occur.
We conducted an epidemiologic study of M. pneumoniae pneumonia in a large
health maintenance organization in Seattle, the Group Health Cooperative, between
1963 and 1975. The membership averaged 150,000. The study included 947 culture-
proven cases of M. pneumoniae pneumonia. Skin rashes were the only noteworthy
complications and occurred in 17 percent of cases [5]. These were usually described
as either urticarial or morbilliform, and in one case as erythema nodosum. A few pa-
tients experienced recurring urticarial rashes for a couple of months before total
recovery [5]. However, in the Group Health studies physicians were only asked to
submit specimens from patients who presented with pneumonia, not from patients
who had neurological or other disease syndromes. Unless such complications were
preceded by pneumonia, unusual manifestations would have escaped notice.
In Seattle, epidemics occurred in 1966-1967 and then again in 1974. The School of
Public Health has the only laboratory that carries out isolation of M. pneumoniae,
and the School serves as a referral center to which physicians not serving the Group
Health population also submit specimens. From the first documented epidemic, we
reported two cases of Stevens-Johnson syndrome with isolates ofM. pneumoniae in
the throat [16,17]. During the 1974 epidemic a 12-year-old boy was seen with septic
arthritis, primarily of the hip joint, and leukopenia with bone marrow suppression.
He also had pneumonia and M. pneumoniae was isolated from his throat (but not
from joint fluid) [unpublished case]. None of these three patients were members of
the Group Health Cooperative but were referred to us from other community physi-
cians. Other referred patients from whom M. pneumoniae was isolated had no
noteworthy complications, although most required hospitalization for pneumonia.
Thus evidence of a high rate of severe complications during an epidemic period was
lacking, but surveillance for complications was casual at best.
In 1980-1981 we observed a third epidemic ofM. pneumoniae pneumonia in Seat-
tle, seven years after the previous one. At this time the Group Health study had been
terminated. Instead, the Seattle-King County Public Health Department, covering a
population of 1.25 million, was monitoring respiratory diseases by offering
serologic diagnosis (complement fixation test using antigen purchased from
Microbiological Associates) to the practicing physicians in the community free of
charge (Fig. 1). In 1979, 6 percent of 299 sera submitted to the health department
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had significant titer rises or a single titer of > 64 to M. pneumoniae. In 1980, the
proportion ofpositives rose to 16 percent of 687 sera tested and, in 1981, 31 percent
of 486 sera tested were positive. The epidemic appeared to have started in March of
1980-the highest incidence was shown between December 1980 and March of 1981;
thereafter the epidemic dissipated. Community physicians were notified about the
epidemic in October of 1980 in a monthly newsletter with a circulation of approx-
imately 2,100. In the same letter sera from cases with complications were solicited in
a concerted effort to evaluate the frequency of severe complications to M.
pneumoniae infections during the epidemic. A questionnaire was subsequently sent
to physicians who could be located and who had patients with significant antibody
titer rises or single titers of 2 64 during the 1980-1981 epidemic. Unfortunately,
names and addresses of physicians who forwarded sera through other laboratories
were not available. Information on age, sex, hospitalization, diagnosis, and com-
plications was requested. A total of 114 (77 percent) of 148 questionnaires were
returned.
An analysis of the information on the questionnaires showed that:
Fifty-six patients (49 percent) whose sera had been forwarded had been
hospitalized-a much higher proportion than the 2 percent observed in our Group
Health studies [2]. Thus, these patients were probably a sub-sample with more
severe disease than the average patient seen in the community with M. pneumoniae
infection.
The majority were adults, whereas children are known to have the highest attack
rates in the general population and consistently constituted almost 80 percent of all
cases in our population-based studies [2]. This probably indicates that M.
pneumoniae disease is more likely to be complicated in adults, as case reports sug-
gest, and/or that pediatricians were less inclined to draw blood samples.
Seventy-seven or 67 percent of those with positive sera had been diagnosed as hav-
471ing pneumonia. The patients without a diagnosed pneumonia were investigated
usually because of signs of a severe respiratory tract infection.
Many minor complications such as myalgia, diarrhea, vomiting, poorly described
skin rashes, pleurisy (six patients), and pleural effusion (two patients) were reported.
The major complications noted were as follows: two cases of acute respiratory
distress syndrome (19 and 62 years old), two cases ofStevens-Johnson syndrome (34
and 37 years old), one case of gross hematuria (39 years old), and one case of em-
pyema (40 years old). Cardiac complications were suspected in two patients (62 and
84 years old) with pneumonia. Hepatitis was encountered in three cases, but drug
reactions or viral hepatitis could not be ruled out. Anemia was also reported but not
described in detail.
Although probably not all physicians treating M. pneumoniae pneumonia in the
community utilized the free diagnostic services, it does not appear that the
1980-1981 epidemic was followed by a marked increase in conditions that are con-
sidered complications to M. pneumoniae infections.
In the U.S., because of the fragmented structure of the health care system, it
would be difficult to arrive 4t reliable estimates ofcomplications to M. pneumoniae
infections. In certain European countries and Japan, which have centralized
laboratory facilities and comprehensive community health care systems, the oppor-
tunities to investigate rates ofcomplications are far better. Thus Lind et al. reported
that, at least in the 1972 epidemic ofM. pneumoniae infections in Copenhagen, there
was an increase in the rate of aseptic meningitis attributed to this organism [18].
Sterner and Biberfeld noticed a high rate of meningitis and meningoencephalitis
among patients hospitalized for M. pneumoniae pneumonia in Stockholm [7].
Assaad et al., who compiled data on neurological diseases with viral and M.
pneumoniae infections from many countries, under the aegis ofWHO, commented
on increased numbers of patients with aseptic and viral meningitis with serological
evidence of M. pneumoniae infections during an epidemic in Finland [19]. Similar
observalions have recently been made in France [20].
Family studies of M. pneumoniae infections offer additional insight into the fre-
quency of complications. In a Seattle family study, the only complications noted
among 59 infected members were two cases with typical bullous hemorrhagic myr-
ingitis and several cases of skin rashes [21]. Balassanian et al. reported a case of
psychosis in an adult woman among 36 family members studied [22]. Biberfeld and
Sterner reported two cases ofacute psychosis in middle-aged women and one case of
myocarditis among 70 family members studied [23].
As far as other complications are concerned, epidemiologic support for signifi-
cant impacts is lacking [24]. Ponka reported that 4.5 percent of Finnish patients
hospitalized with serologic titer rises to M. pneumoniae had myocarditis, but
warned in a later publication that the CF test with glycolipid used as an antigen may
give false positive results, particularly in heart disease [25,26]. On similar grounds,
and because of lack of epidemiological association, Leinikki et al. rejected pan-
creatitis as a complication of M. pneumoniae infection [27].
In summary, in epidemiologic studies ofM. pneumoniae, neurological disease, in-
cluding acute psychosis, has been associated by several authors. Studies in the early
1940s and the later Seattle experience also suggest that cases ofStevens-Johnson syn-
drome occur during epidemics. Population-based studies suggest that other com-
plications attributed toM. pneumoniae are rare. Isolation ofthe organism should be
sought, in addition to serologic titerrise, to document that a disease syndrome is due
to M. pneumoniae, since false positive serologic rises have been demonstrated
[26,27,28].
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